Gut Microbiota as Mediator and Moderator Between Hepatitis B Virus and Hepatocellular Carcinoma: A Prospective Study
ABSTRACT Background The impact of gut microbiome on hepatitis B virus (HBV)‐related hepatocellular carcinoma (HCC) is unclear. We aimed to evaluate the potential correlation between gut microbiome and HBV‐related HCC and introduced novel machine learning (ML) signatures based on gut microbe to predi...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-12-01
|
| Series: | Cancer Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cam4.70454 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832593674932846592 |
|---|---|
| author | Bingren Hu Yi Yang Jiangqiao Yao Ganglian Lin Qikuan He Zhiyuan Bo Zhewei Zhang Anlvna Li Yi Wang Gang Chen Yunfeng Shan |
| author_facet | Bingren Hu Yi Yang Jiangqiao Yao Ganglian Lin Qikuan He Zhiyuan Bo Zhewei Zhang Anlvna Li Yi Wang Gang Chen Yunfeng Shan |
| author_sort | Bingren Hu |
| collection | DOAJ |
| description | ABSTRACT Background The impact of gut microbiome on hepatitis B virus (HBV)‐related hepatocellular carcinoma (HCC) is unclear. We aimed to evaluate the potential correlation between gut microbiome and HBV‐related HCC and introduced novel machine learning (ML) signatures based on gut microbe to predict the risk of HCC. Materials and Methods A total of 640 patients with chronic liver diseases or HCC were prospectively recruited between 2019 and 2022. Fecal samples were collected and subjected to 16S rRNA gene sequencing. Univariate and multivariate logistic regression was applied to identify risk characteristics. Several ML methods were employed to construct gut microbe‐based models and the predictive performance was evaluated. Results A total of 571 patients were involved in the study, including 374 patients with HCC and 197 patients with chronic liver diseases. After the propensity score matching method, 147 pairs of participants were enrolled in the analysis. Bacteroidia and Bacteroidales were demonstrated to exert mediating effects between HBV and HCC, and the moderating effects varied across Bacilli, Lactobacillales, Erysipelotrichaceae, Actinomyces, and Roseburia. HBV, alpha‐fetoprotein, alanine transaminase, triglyceride, and Child‐Pugh were identified as independent risk factors for HCC occurrence. Seven ML‐based HBV‐gut microbe models were established to predict HCC, with AUCs ranging from 0.821 to 0.898 in the training set and 0.813–0.885 in the validation set. Furthermore, the merged clinical‐HBV‐gut microbe models exhibited a comparable performance to HBV‐gut microbe models. Conclusions Gut microbes are important factors between HBV and HCC through its potential mediating and moderating effects, which can be used as valuable biomarkers for the pathogenesis of HBV‐related HCC. |
| format | Article |
| id | doaj-art-426cb512c5554b90b5399b315a2ed53d |
| institution | Kabale University |
| issn | 2045-7634 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Wiley |
| record_format | Article |
| series | Cancer Medicine |
| spelling | doaj-art-426cb512c5554b90b5399b315a2ed53d2025-01-20T10:51:32ZengWileyCancer Medicine2045-76342024-12-011324n/an/a10.1002/cam4.70454Gut Microbiota as Mediator and Moderator Between Hepatitis B Virus and Hepatocellular Carcinoma: A Prospective StudyBingren Hu0Yi Yang1Jiangqiao Yao2Ganglian Lin3Qikuan He4Zhiyuan Bo5Zhewei Zhang6Anlvna Li7Yi Wang8Gang Chen9Yunfeng Shan10Department of Hepatobiliary and Pancreatic Surgery The First Affiliated Hospital of Wenzhou Medical University Wenzhou ChinaDepartment of Epidemiology and Biostatistics, School of Public Health Wenzhou Medical University Wenzhou ChinaDepartment of Hepatobiliary and Pancreatic Surgery The First Affiliated Hospital of Wenzhou Medical University Wenzhou ChinaDepartment of Hepatobiliary and Pancreatic Surgery The First Affiliated Hospital of Wenzhou Medical University Wenzhou ChinaDepartment of Hepatobiliary and Pancreatic Surgery The First Affiliated Hospital of Wenzhou Medical University Wenzhou ChinaDepartment of Hepatobiliary and Pancreatic Surgery The First Affiliated Hospital of Wenzhou Medical University Wenzhou ChinaThe First Clinical College Wenzhou Medical University Wenzhou ChinaThe First Clinical College Wenzhou Medical University Wenzhou ChinaDepartment of Epidemiology and Biostatistics, School of Public Health Wenzhou Medical University Wenzhou ChinaDepartment of Hepatobiliary and Pancreatic Surgery The First Affiliated Hospital of Wenzhou Medical University Wenzhou ChinaDepartment of Hepatobiliary and Pancreatic Surgery The First Affiliated Hospital of Wenzhou Medical University Wenzhou ChinaABSTRACT Background The impact of gut microbiome on hepatitis B virus (HBV)‐related hepatocellular carcinoma (HCC) is unclear. We aimed to evaluate the potential correlation between gut microbiome and HBV‐related HCC and introduced novel machine learning (ML) signatures based on gut microbe to predict the risk of HCC. Materials and Methods A total of 640 patients with chronic liver diseases or HCC were prospectively recruited between 2019 and 2022. Fecal samples were collected and subjected to 16S rRNA gene sequencing. Univariate and multivariate logistic regression was applied to identify risk characteristics. Several ML methods were employed to construct gut microbe‐based models and the predictive performance was evaluated. Results A total of 571 patients were involved in the study, including 374 patients with HCC and 197 patients with chronic liver diseases. After the propensity score matching method, 147 pairs of participants were enrolled in the analysis. Bacteroidia and Bacteroidales were demonstrated to exert mediating effects between HBV and HCC, and the moderating effects varied across Bacilli, Lactobacillales, Erysipelotrichaceae, Actinomyces, and Roseburia. HBV, alpha‐fetoprotein, alanine transaminase, triglyceride, and Child‐Pugh were identified as independent risk factors for HCC occurrence. Seven ML‐based HBV‐gut microbe models were established to predict HCC, with AUCs ranging from 0.821 to 0.898 in the training set and 0.813–0.885 in the validation set. Furthermore, the merged clinical‐HBV‐gut microbe models exhibited a comparable performance to HBV‐gut microbe models. Conclusions Gut microbes are important factors between HBV and HCC through its potential mediating and moderating effects, which can be used as valuable biomarkers for the pathogenesis of HBV‐related HCC.https://doi.org/10.1002/cam4.70454gut‐liver axisgut microbiotahepatitis B virushepatocellular carcinomamachine learning |
| spellingShingle | Bingren Hu Yi Yang Jiangqiao Yao Ganglian Lin Qikuan He Zhiyuan Bo Zhewei Zhang Anlvna Li Yi Wang Gang Chen Yunfeng Shan Gut Microbiota as Mediator and Moderator Between Hepatitis B Virus and Hepatocellular Carcinoma: A Prospective Study Cancer Medicine gut‐liver axis gut microbiota hepatitis B virus hepatocellular carcinoma machine learning |
| title | Gut Microbiota as Mediator and Moderator Between Hepatitis B Virus and Hepatocellular Carcinoma: A Prospective Study |
| title_full | Gut Microbiota as Mediator and Moderator Between Hepatitis B Virus and Hepatocellular Carcinoma: A Prospective Study |
| title_fullStr | Gut Microbiota as Mediator and Moderator Between Hepatitis B Virus and Hepatocellular Carcinoma: A Prospective Study |
| title_full_unstemmed | Gut Microbiota as Mediator and Moderator Between Hepatitis B Virus and Hepatocellular Carcinoma: A Prospective Study |
| title_short | Gut Microbiota as Mediator and Moderator Between Hepatitis B Virus and Hepatocellular Carcinoma: A Prospective Study |
| title_sort | gut microbiota as mediator and moderator between hepatitis b virus and hepatocellular carcinoma a prospective study |
| topic | gut‐liver axis gut microbiota hepatitis B virus hepatocellular carcinoma machine learning |
| url | https://doi.org/10.1002/cam4.70454 |
| work_keys_str_mv | AT bingrenhu gutmicrobiotaasmediatorandmoderatorbetweenhepatitisbvirusandhepatocellularcarcinomaaprospectivestudy AT yiyang gutmicrobiotaasmediatorandmoderatorbetweenhepatitisbvirusandhepatocellularcarcinomaaprospectivestudy AT jiangqiaoyao gutmicrobiotaasmediatorandmoderatorbetweenhepatitisbvirusandhepatocellularcarcinomaaprospectivestudy AT ganglianlin gutmicrobiotaasmediatorandmoderatorbetweenhepatitisbvirusandhepatocellularcarcinomaaprospectivestudy AT qikuanhe gutmicrobiotaasmediatorandmoderatorbetweenhepatitisbvirusandhepatocellularcarcinomaaprospectivestudy AT zhiyuanbo gutmicrobiotaasmediatorandmoderatorbetweenhepatitisbvirusandhepatocellularcarcinomaaprospectivestudy AT zheweizhang gutmicrobiotaasmediatorandmoderatorbetweenhepatitisbvirusandhepatocellularcarcinomaaprospectivestudy AT anlvnali gutmicrobiotaasmediatorandmoderatorbetweenhepatitisbvirusandhepatocellularcarcinomaaprospectivestudy AT yiwang gutmicrobiotaasmediatorandmoderatorbetweenhepatitisbvirusandhepatocellularcarcinomaaprospectivestudy AT gangchen gutmicrobiotaasmediatorandmoderatorbetweenhepatitisbvirusandhepatocellularcarcinomaaprospectivestudy AT yunfengshan gutmicrobiotaasmediatorandmoderatorbetweenhepatitisbvirusandhepatocellularcarcinomaaprospectivestudy |